Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

MRP-S34 Inhibitors

Staurosporine, a kinase inhibitor, can suppress a wide range of kinases, which may include kinases that phosphorylate MRP-S34 or regulate its activity. Rapamycin and LY294002 target the mTOR and PI3K/AKT pathways, respectively, which are central to cellular growth and survival, and could indirectly influence MRP-S34's function within these pathways. MG132 and Bortezomib are proteasome inhibitors that prevent the degradation of proteins, which could lead to an increase in the levels of MRP-S34 or affect its interactions with other proteins. PD98059 and U0126 are specifically MEK inhibitors, affecting the MAPK/ERK pathway that is implicated in cell growth and differentiation, and could modulate MRP-S34's role in these processes. Y-27632 and SB203580 inhibit ROCK and p38 MAP kinase, respectively, which are involved in cytoskeletal organization and stress response pathways. These inhibitors could alter the cellular processes in which MRP-S34 participates. QNZ affect the transcription factor NF-κB, potentially altering the expression of genes that MRP-S34 regulates or responds to. Geldanamycin targets Hsp90, affecting protein folding and stability, and could thereby destabilize MRP-S34 or its associated proteins.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that can suppress the activity of a broad range of kinases potentially upstream or downstream of MRP-S34.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can downregulate signaling pathways involved in protein synthesis and cell proliferation, potentially affecting MRP-S34's role in these processes.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

An immunosuppressant that can inhibit calcineurin, potentially affecting transcription factors and cellular responses that involve MRP-S34.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that can prevent the degradation of proteins, potentially increasing the levels of MRP-S34 or its interacting partners.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that can alter the PI3K/AKT signaling pathway, possibly affecting processes regulated by MRP-S34.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

A MEK inhibitor that can impede the MAPK/ERK pathway, potentially influencing MRP-S34's function within this pathway.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

A ROCK inhibitor that can affect cytoskeletal organization, potentially altering cellular processes involving MRP-S34.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAP kinase inhibitor that can modulate inflammatory responses and stress-activated pathways, possibly affecting MRP-S34's role in these pathways.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that can lead to the accumulation of misfolded proteins, potentially affecting MRP-S34's stability or interactions.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Another MEK inhibitor that can block the MAPK/ERK pathway, potentially influencing processes that MRP-S34 is involved in.